Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEARL: Rapamycin for longevity
NCT04488601Phase 2Completed
- Sponsor
- AgelessRx
- Start
- Jan 2020
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in aging, sponsored by AgelessRx. Started Jan 2020; status: completed.
02
Drugs
sirolimus
03
Conditions
aging
Beyond the preview
Go deeper on NCT04488601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04488601.